We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week

Journal Scan / Research · April 21, 2022

CRP Flare Predicts Response to Anti–PD-L1 Immune Checkpoint Blockade in Metastatic Urothelial Carcinoma

European Journal of Cancer


Additional Info

European Journal of Cancer
C-reactive protein flare predicts response to anti-PD-(L)1 immune checkpoint blockade in metastatic urothelial carcinoma
Eur. J. Cancer 2022 Mar 30;167(xx)13-22, N Klümper, D Sikic, J Saal, T Büttner, F Goldschmidt, J Jarczyk, P Becker, P Zeuschner, M Weinke, C Kalogirou, J Breyer, M Burger, P Nuhn, K Tully, F Roghmann, C Bolenz, F Zengerling, RM Wirtz, M Muders, G Kristiansen, T Bald, J Ellinger, B Wullich, M Hölzel, A Hartmann, P Erben, M Ritter, M Eckstein

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading